2X0B

Crystal structure of human angiotensinogen complexed with renin


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 4.33 Å
  • R-Value Free: 0.334 
  • R-Value Work: 0.309 
  • R-Value Observed: 0.310 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

A Redox Switch in Angiotensinogen Modulates Angiotensin Release.

Zhou, A.Carrell, R.W.Murphy, M.P.Wei, Z.Yan, Y.Stanley, P.L.Stein, P.E.Pipkin, F.B.Read, R.J.

(2010) Nature 468: 108

  • DOI: 10.1038/nature09505
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • Blood pressure is critically controlled by angiotensins, which are vasopressor peptides specifically released by the enzyme renin from the tail of angiotensinogen-a non-inhibitory member of the serpin family of protease inhibitors. Although angiotens ...

    Blood pressure is critically controlled by angiotensins, which are vasopressor peptides specifically released by the enzyme renin from the tail of angiotensinogen-a non-inhibitory member of the serpin family of protease inhibitors. Although angiotensinogen has long been regarded as a passive substrate, the crystal structures solved here to 2.1 Å resolution show that the angiotensin cleavage site is inaccessibly buried in its amino-terminal tail. The conformational rearrangement that makes this site accessible for proteolysis is revealed in our 4.4 Å structure of the complex of human angiotensinogen with renin. The co-ordinated changes involved are seen to be critically linked by a conserved but labile disulphide bridge. Here we show that the reduced unbridged form of angiotensinogen is present in the circulation in a near 40:60 ratio with the oxidized sulphydryl-bridged form, which preferentially interacts with receptor-bound renin. We propose that this redox-responsive transition of angiotensinogen to a form that will more effectively release angiotensin at a cellular level contributes to the modulation of blood pressure. Specifically, we demonstrate the oxidative switch of angiotensinogen to its more active sulphydryl-bridged form in the maternal circulation in pre-eclampsia-the hypertensive crisis of pregnancy that threatens the health and survival of both mother and child.


    Organizational Affiliation

    Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK. awz20@cam.ac.uk



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
RENIN
A, C, E, G
383Homo sapiensMutation(s): 0 
Gene Names: REN
EC: 3.4.23.15
Find proteins for P00797 (Homo sapiens)
Go to UniProtKB:  P00797
NIH Common Fund Data Resources
PHAROS  P00797

Find similar proteins by: Sequence  |  Structure

Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
ANGIOTENSINOGEN
B, D, F, H
452Homo sapiensMutation(s): 0 
Gene Names: AGTSERPINA8
Find proteins for P01019 (Homo sapiens)
Go to UniProtKB:  P01019
NIH Common Fund Data Resources
PHAROS  P01019
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 4.33 Å
  • R-Value Free: 0.334 
  • R-Value Work: 0.309 
  • R-Value Observed: 0.310 
  • Space Group: H 3
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 212.475α = 90
b = 212.475β = 90
c = 474.061γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
MOSFLMdata reduction
SCALAdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2010-10-20
    Type: Initial release
  • Version 1.1: 2011-05-08
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance